Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
The Journal of Infection
|
December 29, 2021
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients
Maria Paz Ventero, Oscar Moreno-Perez, Carmen Molina-Pardines, et al.
International Journal of Clinical Practice
|
July 6, 2021
Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series
Jose-Manuel Ramos-Rincon, Oscar Moreno-Perez, Hector Pinargote-Celorio, et al.
Plos One
|
March 23, 2021
Fatality and risk features for prognosis in COVID-19 according to the care approach - a retrospective cohort study
Mariano Andrés, Jose-Manuel Leon-Ramirez, Oscar Moreno-Perez, et al.
Frontiers in Cardiovascular Medicine
|
November 7, 2022
Early carbohydrate antigen 125 as a mortality predictor in hospitalized patients with coronavirus disease 2019
Oscar Moreno-Perez, Julio Nuñez, Miriam Sandin-Rollan, et al.
Frontiers in Pharmacology
|
October 26, 2023
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
José Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Jara Llenas-García, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes
Matthew P Lennol, Nicholas J Ashton, Oscar Moreno-Pérez, et al.
The Journal of Infection
|
January 15, 2021
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
Oscar Moreno-Pérez, Esperanza Merino, Jose-Manuel Leon-Ramirez, et al.
Plos One
|
June 15, 2018
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study
Jesús Troya, Rocio Montejano, Pablo Ryan, et al.
Journal of the International AIDS Society
|
November 15, 2014
Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study
Joaquín Portilla, Piedad Arazo, Josefa Crusells, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
December 12, 2022
[Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment]
Héctor Pinargote-Celorio, Silvia Otero-Rodríguez, Pilar González-de-la-Aleja, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
The Journal of Infection
|
December 29, 2021
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients
Maria Paz Ventero, Oscar Moreno-Perez, Carmen Molina-Pardines, et al.
International Journal of Clinical Practice
|
July 6, 2021
Clinical Frailty Score vs Hospital Frailty Risk Score for predicting mortality and other adverse outcome in hospitalised patients with COVID-19: Spanish case series
Jose-Manuel Ramos-Rincon, Oscar Moreno-Perez, Hector Pinargote-Celorio, et al.
Plos One
|
March 23, 2021
Fatality and risk features for prognosis in COVID-19 according to the care approach - a retrospective cohort study
Mariano Andrés, Jose-Manuel Leon-Ramirez, Oscar Moreno-Perez, et al.
Frontiers in Cardiovascular Medicine
|
November 7, 2022
Early carbohydrate antigen 125 as a mortality predictor in hospitalized patients with coronavirus disease 2019
Oscar Moreno-Perez, Julio Nuñez, Miriam Sandin-Rollan, et al.
Frontiers in Pharmacology
|
October 26, 2023
A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
José Manuel Ramos-Rincón, Héctor Pinargote-Celorio, Jara Llenas-García, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes
Matthew P Lennol, Nicholas J Ashton, Oscar Moreno-Pérez, et al.
The Journal of Infection
|
January 15, 2021
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study
Oscar Moreno-Pérez, Esperanza Merino, Jose-Manuel Leon-Ramirez, et al.
Plos One
|
June 15, 2018
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study
Jesús Troya, Rocio Montejano, Pablo Ryan, et al.
Journal of the International AIDS Society
|
November 15, 2014
Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study
Joaquín Portilla, Piedad Arazo, Josefa Crusells, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
December 12, 2022
[Mild SARS-CoV-2 infection in vulnerable patients: implementation of a clinical pathway for early treatment]
Héctor Pinargote-Celorio, Silvia Otero-Rodríguez, Pilar González-de-la-Aleja, et al.
Page
of 7